CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Sees Significant Drop in Short Interest

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the target of a large decrease in short interest in November. As of November 30th, there was short interest totalling 100 shares, a decrease of 98.0% from the November 15th total of 4,900 shares. Based on an average daily volume of 34,700 shares, the days-to-cover ratio is presently 0.0 days.

CSPC Pharmaceutical Group Stock Down 2.0 %

OTCMKTS CSPCY traded down C$0.05 during trading hours on Friday, reaching C$2.47. The company’s stock had a trading volume of 110,071 shares, compared to its average volume of 40,522. CSPC Pharmaceutical Group has a 52 week low of C$2.25 and a 52 week high of C$3.82. The firm has a fifty day simple moving average of C$2.88 and a 200-day simple moving average of C$2.91.

CSPC Pharmaceutical Group Increases Dividend

The business also recently disclosed a dividend, which was paid on Thursday, December 5th. Stockholders of record on Friday, November 1st were given a dividend of $0.0575 per share. This is an increase from CSPC Pharmaceutical Group’s previous dividend of $0.06. The ex-dividend date was Friday, November 1st.

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.